Chronic myeloid leukemia among patients with a history of prior malignancies: A tale of dual survivorship-Reference-Cited by-同舟云学术

Chronic myeloid leukemia among patients with a history of prior malignancies: A tale of dual survivorship

Published:2016-10-20 Issue:4 Volume:123 Page:609-616
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Koller Paul B.¹^ORCID,Kantarjian Hagop M.²,Nogueras‐Gonzalez Graciela M.³,Jabbour Elias²,Verstovsek Srdan²,Borthakur Gautam²,Estrov Zeev²,Wierda William G.²,Garcia‐Manero Guillermo²,Ferrajoli Alessandra²,Ravandi Farhad²,O'Brien Susan M.⁴^ORCID,Cortes Jorge E.²

Affiliation:

1. Division of Cancer MedicineThe University of Texas MD Anderson Cancer CenterHouston Texas

2. Department of LeukemiaThe University of Texas MD Anderson Cancer CenterHouston Texas

3. Department of BiostatisticsThe University of Texas MD Anderson Cancer CenterHouston Texas

4. Chao Family Comprehensive Cancer CenterUniversity of California at IrvineOrange California

Funder

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.30362

Reference24 articles.

1. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

2. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

3. Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors

4. Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

5. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for keratinocyte cancers. Part I: Immune-related epidemiology, risk factors, pathogenesis, and immunotherapy management of keratinocyte cancers;Journal of the American Academy of Dermatology;2023-06

2. ‘Secondary chronic myeloid leukemia’: comparison between patients previously exposed or not to chemo- and/or radiotherapy;Leukemia & Lymphoma;2019-07-11

3. Chronic Myeloid Leukemia Following Treatment for Primary Neoplasms or Other Medical Conditions;American Journal of Clinical Pathology;2018-07-09

4. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group;Journal of Clinical Oncology;2017-11-20